STOCK TITAN

Vanguard amendment shows 0 shares in National Vision Holdings (EYE) after realignment

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amendment to its Schedule 13G/A reporting for National Vision Holdings Inc. The amendment states Amount beneficially owned: 0 and Percent of class: 0%. It explains an internal realignment effective January 12, 2026 leading certain subsidiaries to report separately. The filing is signed by Ashley Grim on 03/27/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after internal realignment.

The amendment records 0 shares and 0% ownership in National Vision Holdings, reflecting a reallocation of reporting responsibilities among Vanguard subsidiaries effective January 12, 2026. The text cites SEC Release No. 34-39538 as the regulatory basis for disaggregation.

Practical implication: this is an administrative disclosure of reporting structure rather than an active change in holdings. Future 13G/A or 13D/G filings from the named subsidiaries could show different ownership if positions exist and are reported separately.






63845R107

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does Vanguard report for National Vision Holdings (EYE)?

Direct answer: Vanguard reports 0 shares and 0% beneficial ownership. Supporting context: The amendment attributes the change to an internal realignment on January 12, 2026, after which certain subsidiaries report separately under SEC Release No. 34-39538.

Does the filing indicate Vanguard sold shares of EYE?

Direct answer: No—this amendment does not state a sale. Supporting context: It explains reallocation of reporting among Vanguard entities; the filing records 0 shares beneficially owned and cites internal realignment language.

Who signed the Schedule 13G/A amendment for Vanguard?

Direct answer: The filing is signed by Ashley Grim, Head of Global Fund Administration. Supporting context: The signature block shows the date 03/27/2026 and Vanguard's Malvern, Pennsylvania address is listed in Item 2.

What is the significance of SEC Release No. 34-39538 in this filing?

Direct answer: The release permits reporting disaggregation by subsidiaries. Supporting context: Vanguard cites that release to explain why certain subsidiaries will report beneficial ownership separately following the January 12, 2026 realignment.

Will Vanguard’s subsidiaries likely file separate 13G/A forms for EYE?

Direct answer: The amendment indicates subsidiaries will report separately but does not list filings. Supporting context: The text states subsidiaries that pursue prior strategies "will report beneficial ownership separately," implying potential separate filings in due course.
National Vision

NASDAQ:EYE

View EYE Stock Overview

EYE Rankings

EYE Latest News

EYE Latest SEC Filings

EYE Stock Data

2.18B
77.47M
Specialty Retail
Ophthalmic Goods
Link
United States
DULUTH